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Abstract
In order to guarantee the fulfillment of their complex lifecycle, adult filarial nematodes release millions of microfilariae (MF),
which are taken up by mosquito vectors. The current strategy to eliminate lymphatic filariasis as a public health problem
focuses upon interrupting this transmission through annual mass drug administration (MDA). It remains unclear however,
how many rounds of MDA are required to achieve low enough levels of MF to cease transmission. Interestingly, with the
development of further diagnostic tools a relatively neglected cohort of asymptomatic (non-lymphedema) amicrofilaremic
(latent) individuals has become apparent. Indeed, epidemiological studies have suggested that there are equal numbers of
patent (MF+) and latent individuals. Since the latter represent a roadblock for transmission, we studied differences in
immune responses of infected asymptomatic male individuals (n = 159) presenting either patent (n = 92 MF+) or latent
(n = 67 MF2) manifestations of Wuchereria bancrofti. These individuals were selected on the basis of MF, circulating filarial
antigen in plasma and detectable worm nests. Immunological profiles of either Th1/Th17, Th2, regulatory or innate
responses were determined after stimulation of freshly isolated PBMCs with either filarial-specific extract or bystander
stimuli. In addition, levels of total and filarial-specific antibodies, both IgG subclasses and IgE, were ascertained from plasma.
Results from these individuals were compared with those from 22 healthy volunteers from the same endemic area.
Interestingly, we observed that in contrast to MF+ patients, latent infected individuals had lower numbers of worm nests
and increased adaptive immune responses including antigen-specific IL-5. These data highlight the immunosuppressive
status of MF+ individuals, regardless of age or clinical hydrocele and reveal immunological profiles associated with latency
and immune-mediated suppression of parasite transmission.
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Introduction
Lymphatic filariasis (LF) is a tropical helminth disease that
causes acute and chronic inflammation in patients spanning 72
countries. According to recent reports, an estimated 120 million
people are infected with around 40 million seriously incapacitated
and disfigured by the disease [1,2]. The consequential socioeco-
nomic impact has thus designated this infection a major public
health concern. The infection is provoked by threadlike
nematodes (Brugia malayi, B. timori or W. bancrofti), which are
transmitted by anopheline and culicine mosquitoes. 91% of
infections are caused by W. bancrofti [3] and adult worms release
millions of microfilariae in periodical patterns that then circulate
in the blood [1]. Although the detection of MF has been essential
for diagnosing bancroftian filariasis, to verify asymptomatic latent
infections other tests are required. For example, visualization of
active nematodes (filarial dance sign, FDS) can be determined via
ultrasonography of the lymphatic vessels in scrotal regions [4,5].
The rapid antigen card test can also be employed since this test
measures circulating filarial antigen (CFA) in the plasma [6,7].
Interestingly, CFA screening has revealed that there are roughly
equal proportions of MF+ and MF2 individuals and this latter
group has remained largely undetected and neglected in previous
studies since at the time of diagnosis affected individuals present
no severe pathology [8]. Since circulating MF are indispensable
in terms of transmission, studying the immunological profiles of
latently infected individuals may provide essential information as
to how MF are prevented from developing or traveling to the
periphery and thus, for the development of new therapeutic
strategies.
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Although filarial infections are often chronic and persist over
many years, the majority of patients elicit only few signs of disease
[9]. Nevertheless, regardless of whether the individuals are
microfilaremic or not, non-limited immune reactions can lead to
different clinical manifestations such as lymphedema, urogenital
disorders or hydroceles. Thus, the factor(s) responsible for eliciting
the degree of clinical disease and pathology remain a matter of
debate. However, the general consensus deems that alongside
genetic traits these overt reactions are related to the intensity of the
host’s responses to dead or dying worms [1,10,11,12,13,14] which
are then possibly enhanced by stronger reactions to unrelated
stimuli or secondary infections. In addition, the release of the
bacterial endosymbiont Wolbachia from moribund larvae or adult
worms may also be a factor especially since they trigger innate and
Th1/Th17 adaptive responses [15,16,17,18]. Wolbachia are
essential for worm survival and this unique relationship has
provided an alternative avenue for chemotherapeutic treatment
[19,20,21].
Parasitic helminths are known to elicit dominant Th2 (IL-5, IL-
13) responses whilst simultaneously inducing a suppressive milieu
[22]. A key paradigm in filariasis is that patients with elevated
levels of regulatory responses have high parasite numbers and low
pathological symptoms whereas patients with few or no parasites
and deliberating pathology mount strong filarial-specific responses
[23,24]. With regards to lymphatic filariasis, many studies have
focused on the immunological differences between patients
presenting different degrees of pathology [25,26,27]. For example,
patently infected individuals with no clinical signs of disease are
characterized by down-regulated IL-2 and IFN-c responses with a
shift towards Th2 (IL-4, IL-5) and Treg (IL-10 and TGF-b)
responses: this milieu is thought to be helminth-mediated in order
to evade host defenses and ensure helminth survival [9,10,28,29].
In contrast, patients with chronic pathology display a stronger Th1
immune response [24,29,30] or even a Th17 response [31] which
in turn induces the secretion of VEGF-C which is associated with
the development of filarial lymphedema [20]. Pathological profiles
of filarial-infected patients are also reflected in their Ig responses.
For example, asymptomatic MF+ individuals present elevated
IgG4 levels whereas those with chronic pathology have higher
IgE:IgG4 ratios [32,33]. IgG4 is a non-complement fixating Ig
that binds weakly to effector cell Fc receptors and can compete
with IgE for antigen-binding sites [34,35]. Its secretion from B cells
is mediated by regulatory T cells in an IL-10 and TGF-b
dependent manner [36,37].
As mentioned above, with the introduction of concise diagnostic
tools, field studies have elucidated that in comparison to MF+
individuals there are equal numbers of asymptomatic MF2
patients harboring cryptic infection [7]. Therefore, we deciphered
the immunological profiles of 159 filarial-infected patients which
were classified as patently (n = 92) or latently (n = 67) infected. On
the basis of filarial-specific Ig levels in plasma or cytokine release
following antigen-specific re-stimulation of PBMCs, this compre-
hensive study has determined the differences in adaptive immune
responses between patient groups. Indeed, our data reveal that
MF+ individuals are more strongly immune-suppressed than
amicrofilaremic patients, providing novel insight into immune
responses of MF2 patients who represent an impasse for the
parasite’s continuous transmission.
Methods
Study population and ethics statement
We studied a cohort population of 159 W. bancrofti-infected
asymptomatic males (18–50 years) from an endemic region of
Ahanta West District, Ghana, in 2008. Recruited individuals were
part of a treatment study (ISRCTN15216778). Asymptomatic
criteria was based on the lack of lymphedema; 12 patients did
however show the presence of clinical hydrocele according to
Mand et al. [38], (MF+ n=7 and MF2 n= 5). For comparison,
samples were collected from 22 infection-free volunteers. Since
these volunteers resided in the same region and stemmed from
similar socioeconomic backgrounds they were classified as
endemic normals (EN). Written informed consent was obtained
from all individuals. Ethical clearance for this study was given by
both the University of Bonn Ethics committee (‘‘Ethikkommission
der Medizinischen Fakulta¨t der Rheinischen Friedrich-Wilhelms-
Universita¨t Bonn’’), the Committee on Human Research Publi-
cation and Ethics, University of Science and Technology, Kumasi
and the Liverpool School of Tropical Medicine, UK.
Parasitological assessment
The entire study population was screened for other helminth
infections via stool and urine analysis, furthermore subclinical
malaria infection was determined using NADAL Test (nal von
Minden, Moers, Germany). To verify an ongoing filarial infection
patients were tested for circulating filarial antigen (CFA) which
was detected using the TropBioH ELISA test kit (TropBio,
Townsville, Australia) as described previously [39,40]. Due to
the periodicity of the MF, levels of MF were determined from
blood samples collected between 21–23 h. In short, 1 ml of blood
was filtered through a 5 mm Whatman Nucleopore filter (Karl
Roth, Karlsruhe, Germany), the retained MF were then visualized
via Giemsa staining and microscopically counted. 92 individuals
were MF+ and 67 were MF2. 10 individuals (n = 6 MF+ and n= 4
MF2) were also positive for one other helminth infection (Ascaris
lumbricoides n= 8, Strongyloides stercoralis n= 1, Trichuris trichiura n=
1). As mentioned above, 22 volunteers were diagnosed as
uninfected controls since they were both CFA and MF negative.
Study participants were examined for occurrence of adult filariae
and lymph dilation in the scrotum using a portable ultrasound
machine (SONOSITE 180 Plus, Sonosite, Bothell, USA) equipped
with a 7.5 MHz linear transducer [19]. The number of worm nests
Author Summary
The tropical helminth infection lymphatic filariasis affects
more than 120 million people worldwide and is considered
a major public health concern. Over 90% of infections are
elicited by Wucheria bancrofti and adult worms reside in
the lymphatic system releasing millions of microfilariae
(MF), which periodically circulate in the blood. New
diagnostic tools have provided a method to determine
asymptomatic patients that are amicrofilaremic: a subset
of individuals that have so far been neglected but are of
special interest since these patients represent a dead end
in terms of parasite transmission. Therefore, we were
interested in determining whether the absence of MF was
associated with distinct immunological profiles and
observed that indeed responses in MF+ patients were
dampened. From the viewpoint of the helminth such
overall suppression of immune responses may facilitate MF
transmission. Latent individuals however, presented ele-
vated filarial specific responses and extrapolating these
findings to the host provides novel insight into possible
protective mechanisms which either actively hinders the
release of MF from worms or their travel to the periphery.
Further research into these aspects may broaden the range
of strategies currently employed to reduce transmission
and in turn eliminate bancroftian filariasis.
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was determined by detecting movement of adult worms using the
Pulse Wave Doppler mode and all infected patients harbored at
least one detectable worm nest (Filarial Dance Sign, FDS) [4].
Dilation of lymphatics and lymphatic vessels at the position of the
worm nest and the maximum dilation of a lymphatic vessel
(without worms) in the supratesticular area were measured in all
participants (n = 181). The latter parameter was then evaluated
using the following grading system: no dilation= stage 0; minimal
dilation (,0.2 cm)= stage 1; mild dilation (0.21–0.5 cm)= stage 2;
moderate dilation (0.51–1.0 cm) = stage 3 and severe dilation
(.1.1 cm) = stage 4 [38].
Antigens and antibodies
A soluble antigenic extract of Brugia malyi (B.m.) was prepared from
adult worms that developed in Mongolian jirds (Meriones unguiculatus)
as published earlier [41]. Recombinant full-length Plasmodium
falciparum Merozoite Surface Protein 1 (MSP-1) was prepared as
previously described [42]. LPS (Serratia marescens) was obtained from
Sigma-Aldrich (Munich, Germany). B.m. and MSP-1 were tested for
their endotoxin levels using the kinetic Limulus amoebocyte lysate
assay (Charles River, Charleston, SC), the final endotoxin levels in
soluble B.m. extract or MSP-1 were ,0.16EU/ml or ,0.05EU/ml
respectively. Anti-CD3 and anti-CD28 antibodies were purchased
from eBiosciences (Frankfurt, Germany). Secondary antibodies for
IgG1-4 were obtained from Sigma-Aldrich, whereas that for IgE was
purchased from Southern Biotech (Birmingham, USA).
PBMC preparation
Venous blood was collected into EDTA-filled monovettes. Blood
was transported at 4–8uC from field stations to the local laboratory
where PBMCs were directly isolated. In brief, 7 ml of blood was
transferred into Ficoll containing Leucosep tubes (Greiner Bio-One,
Frickenhausen, Germany) and centrifuged for 20 min at 8006g at
room temperature. Plasma layers were removed and frozen until
further use. Cell suspensions were then washed twice with sterile
PBS (8 min at 400g at room temperature and re-suspended in
RPMI 1640 medium (PAA, Linz, Austria), supplemented with 10%
FCS (PAA) and 50 mg/ml of gentamicin (PAA), before counting
with trypan blue (Sigma-Aldrich, Munich, Germany).
In vitro cell cultures
For re-stimulation, 26105 PBMCs/well were plated into 96-well
plates (U-shaped, Greiner Bio-One). PBMCs were left either
unstimulated or stimulated in triplicates with the following stimuli:
B.m. extract (5 mg/ml), anti-CD3/anti-CD28 (10 mg/ml and
2.5 mg/ml, respectively), MSP-1 (0.25 mg/ml), or LPS (50 ng/
ml). Cultures were incubated for 72 hours at 37uC in 5% CO2.
Supernatants were collected and frozen until further use.
Determination of Th-like profiles
Culture supernatants from stimulated PBMCs were thawed on ice
and analyzed for the content of IL-4, IL-5, IL-6, IL-10, IL-13, IL-17,
IFN-c, TGF-b and TNF using R&D Duo set ELISA (R&D Systems,
Wiesbaden-Nordenstadt, Germany) according to the manufacturer’s
instructions. In brief, ELISA plates (Greiner Bio-One) were coated
with 50 ml capture antibody per well overnight. The plates were
blocked for 1 hour with 1% BSA in PBS and subsequently incubated
for 2 hours with 50 ml/well supernatants or standards. Plates were
incubated for 2 hours with 50 ml/well of detection antibody.
Thereafter, plates were incubated in the dark with 50 ml/well
Streptavidin-horseradish-peroxidase for 20 minutes. Finally, 50 ml/
well substrate solution containing TMB [tetramethylbenzidine],
(Sigma-Aldrich) were added to the plates and after 30 minutes the
reaction was stopped with 25 ml/well 2NH2SO4 (Sigma-Aldrich). All
steps were fulfilled at room temperature. The plates were measured
using the SpectraMAX ELISA reader (Molecular Devices, Sunyvale,
USA with wavelength correction (450 nm and 570 nm). Data were
analyzed with SOFTmax Pro 3.0 software.
Analysis of immunoglobulins
Plasma from study participants was investigated for immuno-
globulins (total IgG, IgG1, IgG2, IgG3, IgG4 and IgE) using the
Cytometric Bead Assay Flex Set (Becton Dickinson, Heidelberg,
Germany). Plasma was diluted in RPMI 1640 medium (IgG total,
1:100,000, IgG1, 1:100,000, IgG2-4, 1:20,000, IgE, 1:2,000) and
according to the manufacturer’s instructions incubated with the
appropriate amount of beads for one hour at room temperature.
Afterwards, samples were washed with 500 ml washing buffer for
five minutes at 4006 g and then incubated for two hours in the
dark with their appropriate detection antibody. In the last step,
samples were washed, re-suspended and solved in 200 ml washing
buffer and analyzed by flow cytometry using the FACS-Canto I
(BD). Data were analyzed using FCAP-Array software and BD
FACSArray Bioanalyzer.
Assessment of antigen-specific IgE and IgG subclasses
Individual plasma samples were analyzed for levels of antigen-
specific IgE and IgG1-4. In brief, 96-well polysorb plates (Nunc,
Roskilde, Denmark) were coated overnight at 4uC with 50 ml/well
of 5 mg/ml B.m. extract in PBS (pH 9.6). Plates were washed three
times in 0.05% Tween/PBS (pH 7.2), once in PBS alone and
blocked with 200 ml/well of 1% BSA/PBS for two hours at room
temperature. After an additional washing step, 50 ml/well of diluted
plasma was added in triplicates (1:500 for specific IgG1-4 and 1:20
for specific IgE) and incubated overnight at 4uC. After washing,
50 ml/well of the biotinylated secondary antibodies were added for
two hours at room temperature, IgG1 (1:1,000), IgG2 (1:15,000),
IgG3 (1:4,000), IgG4 (1:15,000); IgE (1:1,000). Following the next
wash, 50 ml/well streptavidin-peroxidase (Roche Diagnostics,
Mannheim, Germany; 1:5,000) was incubated for 45 minutes.
After the final wash, 50 ml/well of substrate solution containing
TMB (tetramethylbenzidine, Sigma-Aldrich, Munich, Germany)
were used and the reaction was stopped with 25 ml/well 2N H2SO4.
The plates were measured as mentioned above. Pooled plasma from
ten patients was used for the generation of calibration curves and
assigned arbitrary units for the specific anti-filarial antibodies. In
plasma from healthy European donors helminth-specific IgG1-4
and IgE were not detectable (data not shown).
Statistical analysis
Statistical analyses were performed using the software SPSS
version 19 (SPSS Schweiz Ag, Zurich, Switzerland), the PRISM 5
programme (GraphPad Software, Inc., La Jolla, USA) and SAS
version 9.2 (SAS Institute Inc. Cary, NC, USA). To compare the
three groups a Kruskal-Wallis-test was performed and, if
significant, followed by Mann-Whitney–U test for the comparison
of two groups. P values of 0.05 or less were considered significant.
Where indicated the Cochran-Armitage test was used to determine
a trend. In addition, data were assessed using a generalized linear
model analysis using age as a covariate.
Results
Clinical evaluation of lymphatic filariasis patients shows
an increased number of worm nests in MF+ individuals
Our study cohort comprised of 159 W. bancrofti-infected male
patients and 22 endemic normal volunteers (EN) from 25 villages
Microfilariae Dampen Host Responses
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in Ghana. Amongst the infected individuals, 92 were micro-
filaremic (MF+) and 67 amicrofilaremic (MF2) and the age
distribution within the groups was similar (Figure S1). Patients
were selected, as part of a larger treatment study, on the basis of
adult worms (FDS+) and CFA+ (Table 1). Patients recruited to the
study were negative for lymphedema (LE). Within the MF+ and
MF2 groups no significant differences could be observed in lymph
dilation measurements monitored at worm nest locations
(Figure 1A). MF+ patients did however possess significantly more
scrotal worm nests when compared to MF2 patients (Figure 1B),
which was confirmed using the Cochran-Armitage trend test
(p,0.001). Although there was a slight positive correlation
between the number of worm nests and the amount of circulating
microfilaria (Spearman r= 0.32, p,0.001), there was no correla-
tion with either the age of the individual or the villages in which
they were residing. With regards to CFA, we also found a positive
correlation (r = 0.68, p,0.001) between the concentration of CFA
and MF. Whereas Figure 1A illustrates the local lymph dilation
around the detected worm nests, Figure 1C depicts the maximal
detectable lymph dilation within the whole scrotal tissue, including
the area of the spermatic cord which is not necessarily co-localized
with the position of worm nests. Here, there was no significant
difference between the two W. bancrofti-infected groups. In EN,
maximal dilation of scrotal lymphatic vessels was also assessed and
they displayed lymph dilation between grades 0 and 2 (Figure 1C).
Participants had participated in MDA with an average of two
rounds anti-filarial therapy (IVM and ALB), the most recent round
being $10 months before start of the study (Table 1). Previous
studies have documented that following such therapy MF reappear
in 77% of infected patients after 12 months [43]. Thus, we
conclude that our asymptomatic amicrofilaremic participants
presented latent infection.
Filarial-specific IL-5 responses are elevated in latently
infected individuals
Although much is known about the immunological differences
between asymptomatic MF+ patients and those with chronic
pathology, little is known about the differences in antigen-specific
responses of asymptomatic patent and latent individuals. To address
the immunological profile of MF+ and MF2 patients, PBMCs were
isolated from infected individuals and EN and stimulated with anti-
CD3/anti-CD28, B.m. extract, MSP-1 and LPS for three days.
Th2-like profiles were determined on levels of IL-5 (Figure 2A–D),
IL-13 (Figure 2E–H) and IL-4 (data not shown) in the supernatant.
IL-5 and IL-13 are typical hallmarks for helminth infections and
Figures 2A and E show that upon unspecific T cell activation, both
groups of infected individuals and EN produced similar levels of
these cytokines. With regards to filarial-specific responses, PBMCs
of MF2 patients made significantly more IL-5 than MF+ individuals
(Figure 2B), whereas EN hardly responded to this antigen at all. As
shown earlier by Limaye et al. [44], when correlating antigen-
specific IL-5 production with the percentage of blood-derived
eosinophils, no significant differences could be observed for either
infected group (data not shown). IL-13 was strongly produced by all
infected individuals with no significant differences between MF+
and MF2 groups. When compared to EN however, both infected
groups produced significantly higher levels of IL-13 (Figure 2F). In
response to MSP-1 and LPS, we could not detect any significant
differences between the two infection groups (Figures 2 C, D, G and
H). IL-4 production was not detected in any of the stimulations (data
not shown).
Amicrofilaremic patients present elevated IL-17
responses
To observe whether there were any diversities in the Th1- and
Th17-like profiles of microfilaremic and amicrofilaremic patients
Figure 1. Active circulation of MF is associated with the number of worm nests. Using ultrasound, infected individuals were examined for
(A) the lymph dilation around the worm nests and (B) for the amount of worm nests (FDS). In addition, patients were also examined for (C) the
maximum degree of their supratesticular lymph dilation, presented as a staging system. Box whisker plots in (A) show median, interquartile ranges
and outliers of individually tested patients. Bars in (B) and (C) show the number of individuals and their correlating amount of worm nests or lymph
dilation respectively. Data in (B) were tested for significance with the Cochran-Armitage trend test (p,0.001).
doi:10.1371/journal.pntd.0001611.g001
Table 1. Characteristics of study population.
MF+ (92) MF2 (67) EN (22)
age 34.68 (18–50) 34.61 (18–50) 32.50 (19–45)
FDS positive positive negative
CFA positive positive negative
Rounds of ivermectin 2.17 2.09 n.d.
Number of scrotal worm
nests
1.80 1.28 0
m-mode average (cm) 0.41 0.36 0
MF count (MF/ml) 979.16 (1–7,590) 0 0
Age: mean (range); rounds of ivermectin: mean; Number of scrotal worm nests:
mean; m-mode: mean; MF count: mean (range).
doi:10.1371/journal.pntd.0001611.t001
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we also measured the secreted levels of IFN-c (Figure 3A–D) and
IL-17 (Figure 3E–H). PBMC from only a limited number of
patients secreted these cytokines upon re-stimulation with B.m.
extract (Figures 3B and F). Similarly, few responders were also
observed upon stimulation with MSP-1 (Figures 3C and G) and
LPS (Figures 3D and H). Indeed, only MF2 patients responded to
MSP-1 in terms of IL-17 production. These responders did not
correlate with those patients that had a subclinical plasmodial
infection. Albeit only in a small portion of the study cohort (19/
181), further statistical analysis revealed that these subclinical
malaria patients did not differ in any of their responses when
compared to the malaria negative patients. Interestingly, when
compared to patently infected patients and EN, the MF2 group
also showed significantly elevated IL-17 responses upon anti-
CD3/anti-CD28 stimulation (Figure 3E). Although non-signifi-
cant, after stimulation with anti-CD3/anti-CD28 the median IFN-
c response of MF+ patients was lower than either of the other two
groups (Figure 3A). These results indicate that neither infected
group displayed a dominant filarial-specific Th1-like response.
Filarial-specific IL-10 is enhanced in latently infected
individuals
Next, using the readout of IL-10 production we analyzed the
regulatory responses of these patients. We found that in our
patient cohort, all IL-10 responses from MF+ patients were lower
than those from MF2 patients irrespective of the applied stimulus.
These included the responses to malaria peptide (Figure 4C) and
LPS (Figure 4D) which were significantly lower when compared to
responses from EN and MF2 patients. These data imply that MF
are able to immunomodulate responses to other parasitic antigens
such as those derived from malaria species as well as to a bacterial
stimulus. Due to the high background production of TGF-b, no
differences could be determined within the different groups,
irrespective of antigen stimulus (data not shown). Finally, we
observed a general down regulation of IL-6 release from PBMCs
in the microfilaremic group when compared to uninfected
individuals and this was irrespective to the applied stimulus
(Figures 4E–H). In the case of T cell activation we also detected a
significant suppression of IL-6 release from PBMCs of patently
infected individuals (Figure 4E), again demonstrating down-
regulated responses in these individuals.
Microfilaremic individuals show dampened TNF
responses
Next, stimulated PBMCs were investigated for their TNF
production since during filariasis this cytokine has been shown to
be a feature of acute infection [45]. Strikingly, after stimulation
with anti-CD3/anti-CD28, B.m. extract, MSP-1 or LPS we found
significantly suppressed TNF responses from MF+ patients when
compared to either EN or the latent infected group (Figure 5A, B,
C and D). These data highlight that by dampening TNF
responses, whether adaptive or innate, there is a potential benefit
for the helminth since reduced responses to MF would enhance
the chances for transmission. In association, the higher levels of
TNF in latent individuals may indicate a possible mechanism in
suppressing MF release or even rapid destruction of MF.
Quantitative assessment of IgG and IgE levels
Alongside IL-5, elevated levels of IgE are a hallmark of helminth
infection [33]. Therefore, we measured the concentrations of total
IgE and IgG subclasses in the plasma of all study participants and
uninfected volunteers (Figures 6 A–E). Microfilaremic patients had
Figure 2. Patent infection alters filarial-specific Th2-like responses. Isolated PBMCs (26105/well) from endemic controls (EN) or filarial-
infected MF+ or MF2 patients were stimulated with either anti-CD3/anti-CD28 (10 mg/ml/2.5 mg/ml; A and E), Brugia malayi extract (B.m., 5 mg/ml; B
and F), MSP-1 0.25 mg/ml; C and G) or LPS (50 ng/ml; D and H) for 72 hours. Thereafter, levels of IL-5 (A–D) or IL-13 (E–H) were measured in the culture
supernatants via ELISA. Graphs show box whiskers with median, interquartile ranges and outliers after background subtraction. Statistical
significances between the indicated groups were obtained after Kruskal-Wallis and Mann-Whitney-U tests.
doi:10.1371/journal.pntd.0001611.g002
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Figure 3. Latent infected patients show elevated IL-17 but not Th1-like responses. Isolated PBMCs (26105/well) from endemic controls
(EN) or MF+ or MF2 patients suffering from LF were stimulated with either anti-CD3/anti-CD28 (10 mg/ml/2.5 mg/ml; A and E), Brugia malayi extract
(B.m. 5 mg/ml; B and F), MSP-1 (0.25 mg/ml; C and G) or LPS (50 ng/ml; D and H) for 72 hours. Thereafter, levels of IFN-c (A–D) or IL-17 (E–H) were
measured in the culture supernatants via ELISA. Graphs show box whiskers with median, interquartile ranges and outliers after background
subtraction. Statistical significances between the indicated groups were obtained after Kruskal-Wallis and Mann-Whitney-U tests.
doi:10.1371/journal.pntd.0001611.g003
Figure 4. Regulatory responses are enhanced in latently infected individuals. Isolated PBMCs from endemic controls (EN) or patients
infected with W. bancrofti were stimulated with anti-CD3/anti-CD28 (10 mg/ml/2.5 mg/ml; A, E), Brugia malayi extract (5 mg/ml, B, F), MSP-1 (0.25 mg/
ml; C, G) or LPS (50 ng/ml, D, H) for 72 hours. Thereafter, culture supernatant was tested via ELISA for cytokine release of IL-10 and IL-6. Graphs show
box whiskers with median, interquartile ranges and outliers after background subtraction. Statistical significances between the indicated groups were
obtained after Kruskal-Wallis and Mann-Whitney-U tests.
doi:10.1371/journal.pntd.0001611.g004
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significantly more IgE when compared to EN (Figure 6A).
Interestingly, these levels were also more pronounced when
compared to the latent infected group (Figure 6A). With regards to
the IgG subclasses, no differences in levels of total IgG1 and IgG3
could be observed between individuals in any of the study groups
(Figure 6B and D). However, both patient groups showed a
significant reduction of IgG2 when compared to EN (Figure 6C).
Although no differences in the levels of IgG4 could be observed
Figure 5. Circulating microfilariae dampen release of TNF. Isolated PBMCs from endemic controls (EN) or patients suffering from LF were
stimulated with anti-CD3/anti-CD28 (10 mg/ml/2.5 mg/ml; A), Brugia malayi extract (5 mg/ml; B), LPS (50 ng/ml; C) or with MSP-1 (0.25 mg/ml; D) for
72 hours. Thereafter, culture supernatant was tested via ELISA for cytokine release of TNF. Graphs show box whiskers with median, interquartile
ranges and outliers after background subtraction. Statistical significances between the indicated groups were obtained after Kruskal-Wallis and
Mann-Whitney-U tests.
doi:10.1371/journal.pntd.0001611.g005
Figure 6. Patently infected individuals present elevated levels of total IgE. Plasma from all three groups was analyzed for the production of
total IgG1 (A), IgG2 (B), IgG3 (C), IgG4 (D) and IgE (E) with the Cytometric Bead Array. (F) shows the ratio of IgG4 and IgE. Graphs show box whiskers
with median, interquartile ranges and outliers. Statistical significances between the indicated groups were obtained after Kruskal-Wallis and Mann-
Whitney-U tests.
doi:10.1371/journal.pntd.0001611.g006
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between the different cohorts (Figure 6E) the ratio of IgG4 and IgE
was significantly reduced in the microfilaremic group when
compared to MF2 and EN individuals (Figure 6F).
MF+ patients display a predominant antigen-specific
IgG4 phenotype
Finally, individual patients were analyzed for their filarial-
specific IgG and IgE expression and results are displayed as ratios
of antigen-specific IgG4 to the other isotypes (Figure 7 A–D). As
expected, the control group produced only background levels of
specific filarial antibodies (Figure 7A–D). Ratios of antigen-specific
IgG4/IgE (Figure 7A), IgG4/IgG1 (Figure 7B), IgG4/IgG2
(Figure 7C) and IgG4/IgG3 (Figure 7D) in the infected groups
were all significantly higher when compared to the EN group. In
contrast to the data generated on the presence of total IgE and
IgG4 (Figure 6F), MF+ patients showed a dominant expression of
filarial-specific IgG4 (Figure 7A). Indeed, this strong IgG4
phenotype in MF+ patients was reflected in all ratios
(Figures 7A–D). Significant differences between MF+ and MF2
groups were found in the ratios of IgG4/IgE (Figure 7A), IgG4/
IgG2 (Figure 7C) and IgG4/IgG3 (Figure 7D). In summary,
patently infected individuals display a strong expression of filarial-
specific IgG4 indicating that circulating MF also influence B cell
responses.
Elevated immune responses of MF2 patients are
independent of age
Previous publications have shown that age may play a role with
regards to cytokine production during filariasis [46] and
interestingly we also found that an increase in age correlated with
increased immune responses. Of note, age distribution was equal
between the infected groups (Figure S1). Therefore, we performed
regression analysis using age as a covariate and log transformed
[log(concentration+0.5)] all data to correct for skewness [47,48].
Statistically however, this did not change our overall results, that
is, PBMCs from latently infected individuals produced more
cytokines upon re-stimulation with various stimuli and also the
results for the immunoglobulin responses stayed the same.
Moreover, upon age correction, additional significant differences
become apparent in the scenario of IL-10 production following
anti-CD3/anti-CD28 stimulation. Indeed, MF+ patients produced
significantly less IL-10 when compared to MF2 individuals
(p = 0.0047) which correlates to the statistical responses observed
with the other stimuli (Figure 4B–D). The only variable for which
we found an interaction between age and MF status was total
IgG3 secretion: here increases in age correlated with elevated
IgG3 in MF2 but less IgG3 in MF+ patients but the latter group
still had more IgG3. In addition, we also observed the effect of
removing our 12 clinical hydrocele patients and interestingly, all
statistical outcomes remained the same as shown in Figures 2–7
with the exception of TNF secretion upon B.m. specific re-
stimulation. Here however, the trend remained. These data
strengthen and confirm other studies which have revealed that it is
the parasitic status and not the clinical condition of the individual
that influences the observed immunological responses [49].
Discussion
Helminths are renowned for their ability to immunomodulate
the host’s immune system to ensure both reproduction and long-
term survival and the filarial nematodes are no exception. Several
reports have deciphered the immunological status of MF+ patients
with those presenting chronic pathology and it appears that the
balance between Th1/Th2, Treg and immunoglobulin responses,
alongside genetic factors of both the parasite and host, may define
whether the infected individual is asymptomatic or develops
lymphedema [28]. However, little has been reported about the
strength and character of immune responses elicited in asymp-
tomatic amicrofilaremic individuals, a cohort of patients which are
epidemiologically interesting since they are a dead end for the
parasite’s life cycle with regards to transmission. To address this
aspect, we studied a cohort of non-lymphedema W. bancrofti-
infected individuals since conclusive differentiation of the infection
status can now be readily achieved using various diagnostic tools
[6,7]. Our data shows that in contrast to amicrofilaremic
individuals, patients with a patent infection have suppressed
responses, which indicates that the parasite actively prevents
unwarranted reactions to the transmission stage of the parasite. In
addition, these findings indicate that latent individuals have
developed immune mechanisms to prevent the development of
microfilariae, or MF reaching the peripheral blood (which is the
normal night-time scenario in all individuals with periodic LF).
Although our patients presented no LE a small proportion had
clinical hydrocele in accordance to Mand et al., [38]. Remarkably,
the presence of hydrocele did not influence the outcome of
dampened responses in the patently infected group, indicating that
these two separate pathological outcomes can influence the
immune responses in a different manner.
Naturally, the dampening of not only antigen-specific responses
but those to bystander antigens would greatly enhance the
parasite’s chance of survival. Support of this hypothesis was
Figure 7. Patent infected patients produce more filarial-specific IgG4. Plasma from all participants was investigated for the presence of
helminth-specific immunoglobulins by ELISA. Plates were coated overnight with 5 mg/ml B.m. extract in PBS (pH= 9.6), incubated with patient and
control plasma overnight and analyzed for specific IgG1-4 and IgE. Presented are the ratios of antigen-specific antibodies IgG4/IgE (A), IgG4/IgG1 (B),
IgG4/IgG2 (C) and IgG4/IgG3 (D). Graphs show box whiskers with median, interquartile ranges and outliers. Statistical significances between the
indicated groups were obtained after Kruskal-Wallis and Mann-Whitney-U tests.
doi:10.1371/journal.pntd.0001611.g007
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clearly observed by the secretion of TNF, since responses of
PBMC isolated from patently infected individuals were strongly
down-regulated regardless of the stimulus. In recent years, there
have been various reports describing the involvement of TNF
during filariasis [45,50,51]. However, the majority of these studies
have investigated differences between infected and EN or between
infected and chronic pathology or between MF+ patients and those
with episodes of acute filariasis (adenolymphangitis). For example,
in studies of acute filariasis, individuals had elevated levels of TNF
in their sera when compared to MF+ patients [50]. In another
study, that compared EN with MF+ patients, TNF responses from
PBMCs of microfilaremic patients were again dampened if their
cells were stimulated with either live L3, live MF or filarial antigen,
although the latter was not significant [51]. Reduced levels of TNF
were also observed in asymptomatic patients (microfilaremia not
determined) when compared to those with chronic pathology [31].
Thus, in correlation with the findings here the presence of
circulating MF dampens TNF responses regardless of whether
these are antigen-specific, bystander or innate. Intriguingly, in vitro
studies have implicated that Wolbachia endobacteria, but not the
worm itself, can elicit TNF secretion from innate host cells in a
TLR-dependent manner [15,16]. Moreover, persistent exposure
to Wolbachia but not bacteria-free nematode extracts, drives
homologous and heterologous tolerance of macrophages to TLR
and CD40 ligands and protects against endotoxin shock in vivo
[52]. Other studies have linked TNF with promoting the
production of vascular endothelial growth factors such as
VEGF-C and VEGF-A [53,54], which reportedly contribute to
the development of lymphodema and hydrocele [20,40]. In
addition to the decreased secretion of TNF from PBMCs of
patently infected individuals we also observed suppressed IL-17
responses. Interestingly, in vitro, rIL-17 can drive TNF production
in macrophages [55] and a combination of rIL-17 and rTNF was
shown to increase the production of angiogenic factors like VEGF,
from fibroblasts [56]. Since we also observed differences in IL-6
production between MF+ and amicrofilaremic individuals and it is
well known that human IL-17 is induced by IL-6 in combination
with TGF-b [57], a hypothetical scenario begins to emerge: worm
death could promote the release of Wolbachia which in turn elicits
TNF production by triggering TLR [58]. Enhanced TNF, and
possibly IL-6, coupled to stronger IL-17 responses could instigate
the production of VEGF and promote the onset of pathology. In
association, studies revolving around the immune responses of
chronic pathology patients observed elevated levels of IL-17 and
TNF [31]. The presence of this cytokine combination in our latent
individuals may reflect a higher susceptibility to pathology
especially since a cross-sectional study has indicated that the onset
of chronic pathology is linked to amicrofilaremic status [59].
Theoretically, the normal release of MF could counterbalance this
immunological milieu circumventing unwarranted responses.
Interestingly, unlike TNF, secretion of IFN-c was not detectable
for any of the tested stimuli except direct T cell activation
(Figure 3A), which showed that microfilaremic patients produced
less IFN-c, albeit insignificantly, than latent infected individuals. In
association, other studies comparing MF+ individuals and those
presenting chronic pathology showed that there were no
significant differences in the numbers of polyclonally activated
Th1 cells [28,31]. With regards to Th2-like responses, all infected
patients produced more IL-5 and IL-13 than the EN upon co-
culture with the helminth antigen. Although a previous study was
unable to observe significant increases of IL-5 expression levels in
MF2 individuals [60], we observed elevated IL-5 responses in
amicrofilaremic patients upon filarial-specific re-stimulation.
Interestingly, this reflects studies performed with the murine
model of filariasis which have revealed that in the absence of IL-5
infected mice present higher and longer microfilaremic burdens
when compared to wildtype strains [61]. Although we could not
confirm a negative correlation between the amount of MF and
secreted levels of IL-5, as described for Onchocerca volvulus infection
[62], we could show that microfilaremic individuals produced less
IL-5 and that MF levels were correlated to the number of worm
nests.
It is generally accepted that during filariasis, IL-10 and TGF-b
play an immunosuppressive role but the source of IL-10 remains
inconclusive [63,64,65,66]. In onchocerciasis, the presence of IL-
10 is clearly associated with a protective immunological scenario:
high IgG4, IL-10 and Treg are associated with low pathology
whereas high levels of IgE, IL-4 and eosinophilia are common in
patients with severe pathology [9,22,64,67]. In contrast to latent
individuals, we found elevated polyclonal IgE levels in MF+
individuals (Figure 6A). Such high levels of IgE may facilitate the
persistence of infection through the production of irrelevant (not
parasite Ag-specific) immunoglobulins, that saturate high affinity
IgE receptors expressed on mast cells which renders them unable
to be specifically cross-linked by parasite antigen [28]. Interest-
ingly, although filarial-specific IL-5 and IL-10 responses were
actually dampened in the presence of microfilaria, the ratio of
antigen-specific IgG4 to IgE became elevated. Since IgG4 and IgE
compete for the same binding sites, determining the ratio provides
an indication about the pathophysiological conditions, that is,
whether the antigen triggers an IgE mediated hypersensitivity
response or whether this response can be blocked by IgG4 [68].
The quantities of specific IgG4 produced in filariasis patients can
be remarkably high. In patients presenting elephantiasis, IgG4
levels are similar to those found in EN (57% and 55% of filarial-
specific IgG respectively) whereas in MF+ carriers the amount is
significantly higher (88%) [33]. Upon analyzing the ratio of
specific IgG4 to IgE and IgG subclasses, we detected a strong
dominance of IgG4 in the microfilaremic group. With regards to
IgE, this confirms a study performed by Jaoko et al. in East Africa
and interestingly, this group determined that specific antibodies
levels reflect infection status rather than chronic lymphatic disease
[49].
In summary, upon comparison with MF+ individuals, amicro-
filaremic patients display an increased profile of TNF, IL-17, IL-
10, IL-6 and filarial specific Th2-like responses. Since age has been
shown to play a role in filarial-specific immune responses, we used
regression analysis to assess the influence of age on our data. In the
majority of our stimulation scenarios, we found that an increase in
age did correlate with increased cytokine production. However,
age did not alter the overall outcome, that is, dampened responses
shown by the MF+ patients, indicating that is the infection status
which determines the immune profile. This elevated cytokine
milieu, both filarial and bystander specific, may contribute to the
induction of other immunological pathways such as VEGF which
in turn promotes overt pathology. In contrast, the immunosup-
pressive pattern in MF+ patients is complemented by the high ratio
of specific IgG4/IgE. The prevalence of IgG4 provides protection
to both host and parasite since it provides a mechanism in order to
counter-regulate high IgE and thus avoid excessive immunopa-
thology. Interestingly we saw the described difference between the
two infected groups, which did not suffer from chronic pathology,
indicating again that the presence of microfilaria seems to be
relevant to induce immunosuppression. Such tempered immune
responses would provide an environment that benefits the
transmission phase of the parasite. The findings herein provide
novel insight into the immunology of asymptomatic amicrofilare-
mic individuals, a previously neglected cohort of patients. Their
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elevated immune responses may provide the key into elucidating
alternative therapeutic treatments which would essentially block
transmission and consequently eradicate the infection.
Supporting Information
Figure S1 Equal age distribution amongst filarial-
infected individuals. Since age has been reported to play role
in filarial-induced immune responses we assessed the age
distribution amongst our infected males. No significant differences
could be observed. Further details of the patients groups can be
observed in Table 1. Symbols represent individuals with each
group MF+ (n = 92) and MF2 (n = 67).
(TIF)
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